Delays longer than 90 days before seeking care for breast cancer were linked to a threefold increase in two-year mortality, particularly affecting older and socially isolated patients, according to a multicenter Spanish study.
The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.
A new systematic review evaluated 20 studies on artificial intelligence in bronchoscopy and found AI systems often performed as well as or better than human experts in tasks such as airway navigation and lymph node classification.
Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.